Drug companies shipped billions of painkillers to communities across America without proper oversight between 2006 and 2012, according to newly released data from the Drug Enforcement Administration (DEA), highlighting the pharmaceutical industry’s role in the opioid epidemic as it faces a possible legal reckoning similar to that which befell the tobacco companies in the 1990s.
The data shows that companies distributed 8.4 billion hydrocodone and oxycodone pills to commercial pharmacies in 2006 and 12.6 billion in 2012. That’s an increase of over 50%.
Over the past year, 10 districts with some of the highest drug overdose death rates in the country, each targeted a county where they focused on prosecuting every readily available case involving fentanyl, fentanyl analogues, and other synthetic opioids, regardless of the drug quantity.
A new era of conservative values are spilling over at a federal and state level, some of which role back laws and precedence which have been in effect for the last sixty years. But they do more than that, some changes like the new HHS ruling for healthcare providers which add the “moral consciousness” clause, give wide latitude to individuals to act out their bias, prejudices and bigotry in ways that haven’t existed since the 1800’s
The role of media in fanning the flames on what is little more than a passing curiosity which would get no mention if related to another industry
Appalachian Regional Prescription Opioid (ARPO) Strike Force Takedown Results in Charges Against 60 Individuals, Including 53 Medical Professionals
Providers who exploit this trust for profit at the expense of health and well being, have no place in healthcare
In keeping with the White House proposal to reduce opiate manufacturing by 30% the DOJ and DEA plan another 10% reduction quota in 2019.
Shortages of opioid drugs such as injectable hydromorphone, morphine, fentanyl and methadone have placed a particularly heavy burden on EDs, ambulatory surgery centers and hospitals. This issue has escalated since HHS declared the opioid epidemic a public health emergency last year.
The United States Drug Enforcement (DEA) has reduced the amount of almost every Schedule II opiate and opioid medication that may be manufactured in the United States in 2017 by 25 percent or more